168 results
Page 5 of 9
DEFM14A
0krm a1bq94
6 Nov 18
Proxy related to merger
12:00am
424B3
78gu1rgg
5 Nov 18
Prospectus supplement
3:51pm
S-4/A
illdwd1tdkb
1 Nov 18
Registration of securities issued in business combination transactions (amended)
5:32pm
S-4/A
EX-10.3
nmmnxvkal7fh81tuq
1 Nov 18
Registration of securities issued in business combination transactions (amended)
5:32pm
S-4/A
EX-10.46
y8ux8pt56wb3req
1 Nov 18
Registration of securities issued in business combination transactions (amended)
5:32pm
8-K
EX-10.2
7272h1h9i pjfwr3
1 Nov 18
OvaScience and Millendo Therapeutics Provide Update on Merger Agreement and Financing
5:01pm
425
EX-10.2
d1x6maw end8
1 Nov 18
Business combination disclosure
5:00pm
8-K
EX-3.1
qdsoey ke
9 Aug 18
OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company
5:19pm
8-K
EX-2.1
olf208
9 Aug 18
OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company
5:19pm
425
EX-2.1
xv6 fccdis08krdh
9 Aug 18
Business combination disclosure
5:17pm
425
EX-3.1
q346 lk7doozxnmqd
9 Aug 18
Business combination disclosure
5:17pm
8-K
EX-99.1
p86aabf3xky
3 May 18
OvaScience Reports First Quarter 2018 Financial Results and Provides Business Update
4:53pm
8-K
ig80vqvzwiptanrmc
3 May 18
OvaScience Reports First Quarter 2018 Financial Results and Provides Business Update
4:53pm